<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05613335</url>
  </required_header>
  <id_info>
    <org_study_id>M02150620</org_study_id>
    <nct_id>NCT05613335</nct_id>
  </id_info>
  <brief_title>Crestal Sinus Technique Using Autologous Fibrin Glue Vs Sticky Bone With Simultaneous Implant Insertion.</brief_title>
  <official_title>Minimal Invasive Crestal Sinus Technique Using Autologous Fibrin Glue Versus Sticky Bone With Simultaneous Implant Insertion. A Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      prospective comparison of minimal Invasive Crestal Sinus Technique Using Autologous Fibrin&#xD;
      Glue Vs Sticky Bone with simultaneous implant insertion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to evaluate the clinical and radiographic outcomes of applying&#xD;
      fibrin glue versus sticky bone in conjunction with crestal sinus lift technique associated&#xD;
      with simultaneous implant insertion.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 18, 2020</start_date>
  <completion_date type="Anticipated">November 10, 2022</completion_date>
  <primary_completion_date type="Actual">February 10, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implant stability</measure>
    <time_frame>3 months</time_frame>
    <description>implant stability using The Ostell ISQ scale: The ISQ scale ranges from 0 to 100 that measures implant stability. The values less than 60 indicate low implant stability; values from 60 to 69 indicate medium stability where values between 70 and 79 indicate high stability.&#xD;
6 implants from each group will be assessed regarding implant stability at 3 months post-operative using this ISQ scale to determine implant stability and data will be analyzed statistically for significance.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bleeding</measure>
    <time_frame>3 months</time_frame>
    <description>Peri-implant mucosal bleeding will be graded using criteria of modified sulcus bleeding index (mBI).&#xD;
Score 0; no bleeding when a periodontal probe was passed along the gingival margin adjacent to the implant.&#xD;
Score 1; isolated bleeding visible spot.&#xD;
Score 2; a confluent red line on the gingival margin was formed by blood.&#xD;
Score 3; heavy or profuse bleeding is present.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiographic evaluation</measure>
    <time_frame>immediate postoperative</time_frame>
    <description>Cone beam computed tomography scan will be taken at preoperative visit to assess:Residual bone height (RBH) which is the distance from the alveolar crest to the floor of the maxillary sinus at the intended implant placement site.&#xD;
Implant protrusion (IP):measured as the distance from the sinus floor to implant apex.&#xD;
Graft height apically (GHa):the distance fom implant apex to the highest level of the grafting material (the new sinus floor).&#xD;
Grafted sinus height (GSH):the distance from the original sinus floor to the new sinus floor which is the implant protrusion plus the graft height beyond the implant apex (IP +GHa).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>implant stability</measure>
    <time_frame>6 months</time_frame>
    <description>implant stability using The Ostell ISQ scale: The ISQ scale ranges from 0 to 100 that measures implant stability. The values less than 60 indicate low implant stability; values from 60 to 69 indicate medium stability where values between 70 and 79 indicate high stability.&#xD;
6 implants from each group will be assessed regarding implant stability at 3 months post-operative using this ISQ scale to determine implant stability and data will be analyzed statistically for significance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding</measure>
    <time_frame>6 months</time_frame>
    <description>Peri-implant mucosal bleeding will be graded using criteria of modified sulcus bleeding index (mBI).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic evaluation</measure>
    <time_frame>6 months</time_frame>
    <description>Cone beam computed tomography scan will be taken at preoperative visit to assess:Residual bone height (RBH) which is the distance from the alveolar crest to the floor of the maxillary sinus at the intended implant placement site.&#xD;
Implant protrusion (IP):measured as the distance from the sinus floor to implant apex.&#xD;
Graft height apically (GHa):the distance fom implant apex to the highest level of the grafting material (the new sinus floor).&#xD;
Grafted sinus height (GSH):the distance from the original sinus floor to the new sinus floor which is the implant protrusion plus the graft height beyond the implant apex (IP +GHa).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Missed Upper Posterior Teeth</condition>
  <arm_group>
    <arm_group_label>fibrin glue group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Maxillary sinus augmentation using autologous fibrin glue with simultaneous implant placement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sticky bone group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Maxillary sinus augmentation using mixture of autologous fibrin glue with bone graft with simultaneous implant placement</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Maxillary sinus augmentation using autologous fibrin glue with simultaneous implant placement</intervention_name>
    <description>Maxillary sinus augmentation using autologous fibrin glue with simultaneous implant placement</description>
    <arm_group_label>fibrin glue group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Maxillary sinus augmentation using mixture of autologous fibrin glue with bone graft with simultaneous implant placement</intervention_name>
    <description>Maxillary sinus augmentation using mixture of autologous fibrin glue with bone graft with simultaneous implant placement</description>
    <arm_group_label>sticky bone group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - a) Patients should be willing to be present for regular timely follow up. b) Residual&#xD;
        bone height range from 5 to 9mm c) Patent ostium of maxillary sinus. d) Patients having&#xD;
        missing maxillary posterior teeth. e) Patient cooperation and compliance are indispensible&#xD;
        for a predictable clinical outcome.&#xD;
&#xD;
        f) Patients free from any systemic disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1) Patients with systemic disease that prevent surgical intervention or bone healing.&#xD;
&#xD;
             2) Patients with acute or chronic maxillary sinusitis. 3) Patients with cyst, tumor or&#xD;
             root tips at the planned surgical site. 4) Heavy smoker patients. 5) Elderly patients&#xD;
             (over 60 years). 6) Patients with Poor oral hygiene or aggressive periodontal&#xD;
             diseases. 7) Lack of motivation or inability to maintain oral hygiene.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mansoura University</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahlya</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2022</verification_date>
  <study_first_submitted>October 27, 2022</study_first_submitted>
  <study_first_submitted_qc>November 10, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2022</study_first_posted>
  <last_update_submitted>November 10, 2022</last_update_submitted>
  <last_update_submitted_qc>November 10, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Crestal sinus lift</keyword>
  <keyword>Autologous fibrin glue</keyword>
  <keyword>Sticky bone</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrin Tissue Adhesive</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

